NCT00126282View on ClinicalTrials.gov

A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

December 31, 2007

Conditions
Obsessive-Compulsive Disorder
Interventions
BEHAVIORAL

behavior therapy

DRUG

D-Cycloserine

Trial Locations (2)

06106

Anxiety Disorders Center, The Institute of Living, Hartford

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00126282 - A Medication Trial Combined With Behavior Therapy for Individuals With Obsessive-compulsive Disorder | Biotech Hunter | Biotech Hunter